Rare disease

Gastrointestinal stromal tumour

15 clinical trials

Quick filters

Clinical trials for Gastrointestinal stromal tumour

15 trials across Europe

See all trials →

Quick filters

15 Clinical trials

Gastrointestinal stromal tumour

Recruiting

InvestigationalNo placebo

Phase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)

InvestigationalNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Imatinib Mesilate
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Endometrial cancer+12

Recruiting

InvestigationalNo placebo

A study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Belzutifan
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Gastrointestinal stromal tumour

Recruiting

Registered drugNo placebo

Study of DCC-3116 and ripretinib combination therapy in patients with advanced gastrointestinal stromal tumor (GIST)

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Dcc-3116
Sponsor:Deciphera Pharmaceuticals Inc.

Contact Research Centre

Lymphoma+6

Recruiting

InvestigationalNo placebo

Study to Find the Right Dose and Safety of Lutetium (177Lu) Edotreotide and Arginine-Lysine in Children with Somatostatin Receptor-Positive Tumors

InvestigationalNo placebo

France

Participants:0–17 years
Substances:L-Arginine Hydrochloride
Sponsor:ITM Solucin GmbH

Contact Research Centre

Endometrial cancer+18

Recruiting

InvestigationalNo placebo

Study on the Effectiveness and Safety of BAY 2927088 for Patients with Advanced Solid Tumors with HER2 Mutations

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Bay 2927088
Sponsor:Bayer AG

Contact Research Centre

Gastrointestinal stromal tumour

Recruiting

Registered drugNo placebo

Study on the Effectiveness of Imatinib for Patients with Intermediate-Risk Gastrointestinal Stromal Tumor and High Genomic Grade Index

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Imatinib Mesilate
Sponsor:Centre Hospitalier Regional De Marseille

Contact Research Centre

See all trials →

Gastrointestinal stromal tumour

Clinical trials for Gastrointestinal stromal tumour

Gastrointestinal stromal tumour

Phase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)

Endometrial cancer+12

A study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.

Gastrointestinal stromal tumour

Study of DCC-3116 and ripretinib combination therapy in patients with advanced gastrointestinal stromal tumor (GIST)

Lymphoma+6

Study to Find the Right Dose and Safety of Lutetium (177Lu) Edotreotide and Arginine-Lysine in Children with Somatostatin Receptor-Positive Tumors

Endometrial cancer+18

Study on the Effectiveness and Safety of BAY 2927088 for Patients with Advanced Solid Tumors with HER2 Mutations

Gastrointestinal stromal tumour

Study on the Effectiveness of Imatinib for Patients with Intermediate-Risk Gastrointestinal Stromal Tumor and High Genomic Grade Index

Filter the trials

Prefer not to search? Our Concierge searches the trials for you.